Anne Kleijn

1.7k total citations
15 papers, 692 citations indexed

About

Anne Kleijn is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Anne Kleijn has authored 15 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Anne Kleijn's work include Virus-based gene therapy research (8 papers), CAR-T cell therapy research (6 papers) and Glioma Diagnosis and Treatment (6 papers). Anne Kleijn is often cited by papers focused on Virus-based gene therapy research (8 papers), CAR-T cell therapy research (6 papers) and Glioma Diagnosis and Treatment (6 papers). Anne Kleijn collaborates with scholars based in Netherlands, United States and Germany. Anne Kleijn's co-authors include Martine L.M. Lamfers, Clemens M.F. Dirven, Jenneke J. Kloezeman, Sieger Leenstra, Giulia Fulci, Jeroen de Vrij, Reno Debets, Rutger K. Balvers, Theo M. Luider and Elly M. Hol and has published in prestigious journals such as PLoS ONE, Radiology and Clinical Cancer Research.

In The Last Decade

Anne Kleijn

15 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Kleijn Netherlands	13	361	274	237	159	157	15	692
Catherine P. Langford United States	15	259 0.7×	367 1.3×	293 1.2×	195 1.2×	130 0.8×	22	719
Maria C. Speranza United States	12	463 1.3×	460 1.7×	427 1.8×	200 1.3×	113 0.7×	21	982
Jordi Martínez‐Quintanilla Spain	13	397 1.1×	415 1.5×	448 1.9×	110 0.7×	217 1.4×	20	845
Justin C. Roth United States	14	403 1.1×	394 1.4×	392 1.7×	156 1.0×	95 0.6×	25	800
Alena Cristina Jaime‐Ramirez United States	18	437 1.2×	496 1.8×	288 1.2×	408 2.6×	43 0.3×	24	1.0k
Todd Machemer United States	18	751 2.1×	221 0.8×	358 1.5×	121 0.8×	50 0.3×	28	1.1k
Ian M. Kaplan United States	8	775 2.1×	201 0.7×	164 0.7×	202 1.3×	77 0.5×	16	1.2k
Adam M. Sonabend United States	13	531 1.5×	348 1.3×	357 1.5×	54 0.3×	225 1.4×	16	780
Mai Johnson United States	15	700 1.9×	318 1.2×	447 1.9×	321 2.0×	28 0.2×	22	1.2k
Surya Murty United States	13	231 0.6×	229 0.8×	112 0.5×	127 0.8×	57 0.4×	25	825

Countries citing papers authored by Anne Kleijn

Since Specialization

Citations

This map shows the geographic impact of Anne Kleijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Kleijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Kleijn more than expected).

Fields of papers citing papers by Anne Kleijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Kleijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Kleijn. The network helps show where Anne Kleijn may publish in the future.

Co-authorship network of co-authors of Anne Kleijn

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Kleijn. A scholar is included among the top collaborators of Anne Kleijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Kleijn. Anne Kleijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Meulen‐Muileman, Ida H. van der, Martine L.M. Lamfers, Anne Kleijn, et al.. (2025). Adenovirus-Neutralizing and Infection-Promoting Activities Measured in Serum of Human Brain Cancer Patients Treated with Oncolytic Adenovirus Ad5-∆24.RGD. International Journal of Molecular Sciences. 26(2). 854–854. 3 indexed citations

Vincent, Arnaud J.P.E., Cristina Teodósio, Jeroen Koets, et al.. (2020). Monocytes carrying GFAP detect glioma, brain metastasis and ischaemic stroke, and predict glioblastoma survival. Brain Communications. 3(1). 10 indexed citations

Kleijn, Anne, Charlotte E. Teunissen, Jane S.A. Voerman, et al.. (2018). Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment. Neuro-Oncology. 20(11). 1494–1504. 62 indexed citations

Verheul, Cassandra, Anne Kleijn, & Martine L.M. Lamfers. (2017). Cerebrospinal fluid biomarkers of malignancies located in the central nervous system. Handbook of clinical neurology. 146. 139–169. 13 indexed citations

Kleijn, Anne, Zineb Belcaid, Jenneke J. Kloezeman, et al.. (2017). The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8+T Cell Anti-tumor Activity. Molecular Therapy — Oncolytics. 5. 11–19. 33 indexed citations

Kleijn, Anne, Jenneke J. Kloezeman, Rutger K. Balvers, et al.. (2016). A Systematic Comparison Identifies an ATP‐Based Viability Assay as Most Suitable Read‐Out for Drug Screening in Glioma Stem‐Like Cells. Stem Cells International. 2016(1). 5623235–5623235. 18 indexed citations

Balvers, Rutger K., et al.. (2015). ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells. Journal of Translational Medicine. 13(1). 74–74. 28 indexed citations

Pont, Lotte M.E. Berghauser, Anne Kleijn, Jenneke J. Kloezeman, et al.. (2015). The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells. PLoS ONE. 10(5). e0127058–e0127058. 48 indexed citations

Farrar, Christian T., Jason S. Buhrman, Guanshu Liu, et al.. (2015). Establishing the Lysine-rich Protein CEST Reporter Gene as a CEST MR Imaging Detector for Oncolytic Virotherapy. Radiology. 275(3). 746–754. 61 indexed citations

10.

Vrij, Jeroen de, Sybren L. N. Maas, Kitty M.C. Kwappenberg, et al.. (2015). Glioblastoma‐derived extracellular vesicles modify the phenotype of monocytic cells. International Journal of Cancer. 137(7). 1630–1642. 163 indexed citations

11.

Jiang, Hong, Karen Clise-Dwyer, Kathryn Ruisaard, et al.. (2014). Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model. PLoS ONE. 9(5). e97407–e97407. 103 indexed citations

12.

Kleijn, Anne, Jenneke J. Kloezeman, Giulia Fulci, et al.. (2014). The In Vivo Therapeutic Efficacy of the Oncolytic Adenovirus Delta24-RGD Is Mediated by Tumor-Specific Immunity. PLoS ONE. 9(5). e97495–e97495. 59 indexed citations

13.

Kleijn, Anne, Jenneke J. Kloezeman, Giulia Fulci, et al.. (2014). The therapeutic efficacy of the oncolytic virus Delta24-RGD in a murine glioma model depends primarily on antitumor immunity. OncoImmunology. 3(9). e955697–e955697. 12 indexed citations

14.

Balvers, Rutger K., Anne Kleijn, Jenneke J. Kloezeman, et al.. (2013). Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix–associated gene modules. Neuro-Oncology. 15(12). 1684–1695. 50 indexed citations

15.

Kleijn, Anne, John W. Chen, Jason S. Buhrman, et al.. (2011). Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging. Clinical Cancer Research. 17(13). 4484–4493. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact